Follow The Filings

TBI TrueBlue

TrueBlue earnings company data as of 7:50 PM ET 10/23

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 4 Nov EPS 0.21 — —
Rev — — —

Insider trades

Open-market buys and sales by TBI's executives, directors and 10% owners in the last 12 months, from their Form 4s

All TBI insider trades
  • $149K bought by 3 insiders
  • $15K sold by 1 insider outside a trading plan
  • None no planned (10b5-1) sales
  1. Sonita Lontoh Director
    Sale
    $15K 2,186 shares at $6.73 2.9% of stake
    Traded Jun 5 Filed Jun 8
    ↗
  2. Garrett Ferencz EVP, Chief Legal Officer
    Buy
    $25K 7,000 shares at $3.61 +3.1% to stake
    Traded Feb 25 Filed Feb 26
    ↗
  3. Taryn R Owen CEO
    Buy
    $77K 20,400 shares at $3.79 +2.6% to stake
    Traded Feb 24 Filed Feb 26
    ↗
  4. Carl Schweihs CFO
    Buy
    $47K 12,500 shares at $3.72 +4.5% to stake
    Traded Feb 23 Filed Feb 24
    ↗

Also filed in the last 12 months, not counted as buying or selling: 20 share withholdings for taxes and 14 stock grants.

SEC filings

Recent issuer filings from EDGAR, 19 shown.

Filed Form Detail Links
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-Q TRUEBLUE FORM 10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.07,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 1.01,3.03,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-Q TRUEBLUE FORM 10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
DEF 14A DEFINITIVE PROXY STATEMENT Filing Doc
8-K 1.01,7.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
DEFA14A ADDITIONAL DEFINITIVE PROXY SOLICITING MATERIALS Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.